Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Non-Current Debt (2023 - 2025)

Moolec Science (MLECW) posted Non-Current Debt of $1.3 million for Q2 2025, down 93.04% sequentially from $19.4 million in Q4 2024, and down 98.94% YoY from $127.2 million in Q2 2024.

Moolec Science (MLECW) Non-Current Debt (2023 - 2025) Analysis & Trends

Moolec Science has reported Non-Current Debt for 3 years, with the latest figure at $1.3 million in Q2 2025.

  • Quarterly Non-Current Debt fell 98.94% year-over-year to $1.3 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.3 million (down 98.94% YoY) and the FY2025 annual result came in at $1.3 million, down 98.94% from the prior year.
  • Non-Current Debt declined to $1.3 million in Q2 2025 per MLECW's latest filing, from $19.4 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $127.2 million in Q2 2024 and troughed at $1.2 million in Q1 2023.
  • A 3-year average of $26.6 million and a median of $5.2 million in 2023 frame the typical range for Non-Current Debt.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt soared 4897.49% in 2024, then tumbled 98.94% in 2025.
  • Over 3 years, Non-Current Debt stood at $7.8 million in 2023, then jumped by 146.91% to $19.4 million in 2024, then slumped by 93.04% to $1.3 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $1.3 million, $19.4 million, and $127.2 million for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 882.16 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 360.97 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 8.96 Bn
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.35 Mn
Dec 31, 2024 19.37 Mn
Jun 30, 2024 127.25 Mn
Dec 31, 2023 7.85 Mn
Jun 30, 2023 2.55 Mn
Mar 31, 2023 1.18 Mn